Lithium interferes with reserpine‐induced dopamine depletion
Avinoam Reches, Mohamed N. Hassan, V. Jackson, Stanley Fahn
Abstract
Avinoam Reches, Mohamed N. Hassan, V. Jackson, Stanley Fahn
Abstract
Long-term lithium treatment attenuated the hypokinetic effect of reserpine in a patient with tardive dyskinesia. In rats, prophylactic lithium administration inhibits reserpine-induced dopamine depletion in the brain. These data indicate that lithium may limit the therapeutic efficacy of reserpine in tardive dyskinesia.
OpenAlex reports 7 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Long-term lithium treatment attenuated the hypokinetic effect of reserpine in a patient with tardive dyskinesia. In rats, prophylactic lithium administration inhibits reserpine-induced dopamine depletion in the brain. These data indicate that lithium may limit the therapeutic efficacy of reserpine in tardive dyskinesia.
Key concepts: Reserpine, Tardive dyskinesia, Lithium (medication), Dopamine, Dyskinesia, Tetrabenazine, Pharmacology, Medicine